Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Post-spinal Shivering in Cesarean Section
NCT06942000Phase 3Not yet recruiting
- Sponsor
- Al-Azhar University
- Start
- May 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in post-spinal shivering (PSS) (3 arms), sponsored by Al-Azhar University. Primary endpoint: Efficacy on the incidence and severity of shivering associated with spinal anesthesia. Planned start May 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
post-spinal shivering (PSS)
Beyond the preview
Go deeper on NCT06942000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06942000.